Fluoroquinolone use and fluoroquinolone-resistant pseudomonas aeruginosa is declining in US academic medical centre hospitals

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 6, 2012, Pages 1562-1564

  Pakyz, Amy L ^a   Lee, Jin A ^a   Ababneh, Mera A ^a   Harpe, Spencer E ^a   Oinonen, Michael J ^b   Polk, Ron E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University HealthSystem Consortium ^*  (United States)

Author keywords

Antimicrobial use; Ciprofloxacin resistance; Pseudomonas resistance

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CROSS-SECTIONAL STUDY; DRUG USE; FLUOROQUINOLONE RESISTANT PSEUDOMONAS AERUGINOSA; HOSPITAL; INFECTION CONTROL; LETTER; LONGITUDINAL STUDY; NONHUMAN; PSEUDOMONAS AERUGINOSA; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; FEMALE; FLUOROQUINOLONES; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; UNITED STATES; YOUNG ADULT;

EID: 84861117358     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks083     Document Type: Letter

References (6)

1. Hsu DI, Okamoto MP, Murthy R et al. Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes. J Antimicrob Chemother 2005; 55: 535-41.
2. Ray GT, Baxter R, DeLorenze GN. Hospital-level rates of fluoroquinolone use and the risk of hospital-acquired infection with ciprofloxacinnonsusceptible Pseudomonas aeruginosa. Clin Infect Dis 2005; 41: 441-9.
3. Zervos MJ, Hershberger E, Nicolau DP et al. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin Infect Dis 2003; 37: 1643-8.
4. Polk RE, Johnson CK, McClish D et al. Predicting hospitals rates of fluoroquinolone-resistant Pseudomonas aeruginosa use in US hospitals and their surrounding communities. Clin Infect Dis 2004; 39: 497-503.
5. Pakyz AL, MacDougall C, Oinonen M et al. Trends in antibacterial use in US academic health centers:2002to2006.Arch Intern Med 2008;20: 2254-60.
6. Harbarth S, Harris AD, Carmeli Y et al. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis 2001; 9: 1462-8.